Mobilization with etoposide and granulocyte colony-stimulating factor can replace bone marrow harvesting in patients with malignant lymphoma who previously failed to mobilize sufficient stem cells with cyclophosphamide and G-CSF.
Scheid
C
C
Reiser
M
M
Draube
A
A
Josting
A
A
Fuchs
M
M
Chemnitz
J
J
Winter
S
S
Schultz
A
A
Engert
A
A
Diehl
V
V
Söhngen
D
D
D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000592:standards; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000592:standards; D005047:Etoposide / Q000008:administration & dosage / Q000592:standards; D006085:Graft Survival; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000592:standards; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods* / Q000592:standards; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods / Q000592:standards; D006801:Humans; D007937:Leukapheresis / Q000379:methods; D008223:Lymphoma / Q000628:therapy*; D008875:Middle Aged
D000972:Antineoplastic Agents, Phytogenic; D016179:Granulocyte Colony-Stimulating Factor; D005047:Etoposide; D003520:Cyclophosphamide